Abstract: NLE (Newbouldia laevis (P.Beauv)) is used in folk medicine to treat diabetes. The aim of the study was to isolate and characterize the active compound responsible for the antidiabetic activity.This was carried out using standard in vivo and in vitro models in rats. The antidiabetic activities were evaluated using alloxan-induced diabetes in male and female albino rats after an over night fast and various doses of NLE and glibenclamide, the reference drug 2.0 mg/kg. Bioassay-guided isolation/fractionation techniques were used to isolate the active compound. Characterization of the active compound was carried out including molecular and structural elucidation using NMR (nuclear magnetic resonance) and Gas-Chromatography Mass spectroscopy. The extract caused 60.2% reduction in the FBS (fasting blood sugar) of diabetic rats. Bioassay-guided fractionation of NLE yielded ten (10) fractions with F9 (fraction nine) as the active fraction, which caused 66.0% reduction of FBS in alloxan-induced diabetic rats. Further purification using preparative TLC (thin layer chromatography), gave sub-fraction 9.2 as the active compound. Sub-fraction 9.2 reduced the FBS by 61.4%. The characterization of F9:2 using nuclear magnetic resonance and MS (mass spectroscopy) confirmed it to be a polyunsaturated fatty acid with a molecular weight of 358.56 g.
Introduction


Apart from being the primary source of food for animals including humans, a great proportion of plant species have shown over times to have wonderful medicinal values [1, 2] . Some of the plants have shown to have some antidiabetic effects over the years [1, 3, 4] . Newbouldia leavis (P. Beauv) Seemann ex. Bureau is one of such plants. It is a tree of the family Bignoniaceae in the order Bignoniae. It is a genus of one species. It is a medium size angiosperm tree that grows up to 7-8 m. It can also be a shrub of about 3 m and widely distributed in the tropics. It is shrubby or erect with vertically ascending branches. The leaves are oblanceolate to broadly elliptic with serrated or entire margins. The flowers are pink or whitish. The conjunctivitis. The leaves are also used as chieftaincy leaf in Yoruba land [7] . The stem bark is used for toothache, febrifuge, stomach and skin infections [6, 7] . Recently, the flowers and leaves have been used in the treatment of diabetes [10] and [11] [12] [13] respectively. It is also used to stop vaginal bleeding in threatened abortion [7] and had shown strong antioxidant activity [8] . The aim of the study was to isolate and characterize the active compound responsible for the antidiabetic activity. This becomes imperative because there is paucity of information on bioassay-guided isolation of African plants constituents. Most of the research deals purely with phytochemicals [2] . This was carried out using standard in vivo and in vitro models in rats.
Materials and Methods
The animals used for this experiment were albino wistar rats of both sexes. They were obtained from the animal breeding unit of the College of Health Sciences, Benue State University Makurdi, Benue State Nigeria. They were housed in steel cages in houses with ambient temperature of [27] [28] [29] [30] [31] [32] [33] [34] [35] o C and a lighting period of about 12 hours day and night and a relative humidity of 40-60 %. They were supplied with clean drinking tap water and fed ad-libitum with standard commercial pelleted feed (Vital feed® , Nigeria) except when their fasting blood sugar was required. All ethical conditions governing the use of animals for experiments were observed as stipulated [14] [15] [16] . The male and female rats were kept in separate cages during the period of the experiment. One kilogramme (1 kg) of the leaves of Newbouldia laevis "Aduruku" "Ogirisi" "Akoko" or "Kontor" was collected in Makurdi, Benue State after the plant was identified by Mr. The selected albino rats were fasted between 15-18 hours. Their fasting blood sugar levels were determined with the blood from their tail vein using autoanalyzer (Accu-Check Advantage II® glucose kits). Diabetes was induced by single intraperitoneael administration of alloxan monohydrate at 150 mg/kg body weight as described by Szudelski [17] . The FBS (fasting blood sugar) of the rats was monitored every other day until diabetes was established about the sixth day. Rats with FBS ≥ 7.0 mMol/L were considered diabetic [3, 18] and were selected for subsequent experiments.
Effect of the Crude Extract of NLE on Alloxan-Induced Diabetes in Rats.
In this experiment, twenty-five (25) alloxan-induced diabetic rats were used. The rats were randomly divided into 5 groups of 5 rats per group. Their initial fasting blood sugar was measured at 0 h after which they were treated as follows. Group 1 rats received 10 ml/kg body weight of distilled water and served as negative control. Group 2 rats received 2 mg/kg body weight of glibenclamide, a standard antidiabetic drug and served as positive control while groups 3-5 rats served as NLE treatment groups and were given 62.5, 125.0 and 250.0 mg/kg of the extract respectively. All the treatments were given orally through intragastic tube. The FBS of the rats were measured at 0, 1, 3, 6 and 24 hours post drug/extract administration using an autoanalyzer (Accu-Check Advantage II® kits). The blood used for FBS measurement was collected from the tail vein. The percentage reduction in the FBS at each time was calculated.
Bioassay Guided Fractionation/Determination of Active Compound
Column chromatography was carried out as described by Harbourne [19] 
Screening of Fractions of NLE for Bioactivity/Selection of Active Compound
Thirty six rats were used in this experiment. Diabetes was induced as described earlier and the rats were randomly divided into 12 groups of 3 rats per group. They were fasted for 15 hours and treated as follows;
Group 1 served as negative control and received 10 ml/kg distilled water. Group 2 served as positive control and received 2 mg/kg glibenclamide while groups 3-12 received 50 mg/kg of the various fractions of NLE (Fractions 1-10) respectively through intragastric tube orally. The FBS of the rats were measured at 0, 1, 3, 6 and 24 hours after treatment using Accu-Check Advantage II ® kits. The percentage reduction for each fraction was calculated and the fraction with the highest percentage reduction of blood glucose level was selected as the active fraction for further work.
Purification of the Active Fraction/Isolation of Pure Compound
This was carried out through preparative thin-layer chromatography as described by Stahl [20] . The prepared plates were activated in the oven at a temperature of 110 o C for 1 hour before they were used.
The active fraction was dissolved in methanol and a modified capillary tube was used to streak the solution on the activated plate from one side to the other in a straight line band form and allowed to dry on the plate. Meanwhile a standard chromatographic tank that can contain the 20 x 20 cm plates was saturated with predetermined solvent system (Chloroform : Ethylacatate : Methanol: Formic acid in the ratio: 3:1:2:0.05). Two plates were introduced into the tank at the same time inclined at an angle of 30 o from the edge of the tank. The eluting solvent was allowed to run a distance of ≥ 15 cm starting from the streaked end after which the plates were removed and dried. Each plate was observed under ultra-violet lamp at 254 and 365 nM wavelength in a dark corner and the separated zones or bands were marked with a pin. This process was repeated several times on many plates. The separated zones or bands were scraped into different centrifuge tubes with the aid of a spatula. They were dissolved in methanol and centrifuged at 3000 rpm for 10 minutes. This was to ensure proper separation of the eluent from the adsorbent (silica gel). The collected eluent in methanol was pooled for a particular band (based on R f and colour reaction) and evaporated to dryness using a hot air oven at 40 o C. The resulting compound was weighed, labeled, sealed and stored in the refrigerator until when needed.
Determination of the Active Fraction
Twenty-four (24) albino diabetic rats were used. Diabetes was induced as earlier described. The rats were randomly divided in 8 groups of 3 rats each and treated as follows: group 1 was given 10 ml distilled water/kg, group 2 received 2 mg/kg of glibenclamide while groups 3-8 received 5 mg/kg of the compounds from the active fraction (F9: 1-6). The FBS of the rats were measured at 0, 1, 3, 6 and 24 hours. The compound with the highest antihyperglycaemic activity was selected as the active compound.
Thin-Layer Chromatography of the Active Fraction
Analytical TLC was carried out on the active compound using precoated silica gel (G f254 ) and sprayed with vanillin-sulpheric acid prepared by dissolving 0.16 g of vanillin in 30 ml of concentrated tetraoxosulphate (VI) acid (H 2 S0 4 ) in an atomizer. The plate was viewed under the UV (ultraviolet) lamp at 254 and 365 nM wavelengths. The colour reaction was observed and R f value calculated using the formula described earlier. This test is usually carried out to check those compounds that may not be visualized due to lack of noticeable colour reaction on the TLC plate.
Characterization and Structural Elucidation of the Pure Compound Using NMR (Nuclear Magnetic Resonance) and Mass Spectroscopy
Structural elucidation and characterization of the pure active compound was carried out using 13 C (thirteen carbon) and hydrogen or proton ( 1 H) NMR (nuclear magnetic resonance) and GC-MS (gas chromatography-mass spectroscopy) at the SIPBS (strathclyde institute of pharmacy and biomedical sciences) Laboratory, University of Strathclyde, Glassgow, United Kingdom. Before running the NMR, deuterated acetone was used to check the purity of the sample or to identify the type of sample. Later the sample was dissolved in DMSO (dimethylsulfoxide) before running the NMR. This enables the instrument to achieve field frequency stabilization. The dissolved sample was then transferred to the NMR tube and then run with a Bruker TopSpin 450 Hz programme. 13 CNMR was used to obtain information on the number of carbon atoms in the molecule and 1 HNMR spectroscopy for information on the number of protons. There after GC-MS was used to obtain detailed information on bound connectivity and assignments of chemical shifts from which the structure of the pure compound was elucidated [21] .The initial temperature of the GC-MS was 120 o C for 2 min which was programmed at 5 o C /min up to 200 o C for ramp 1 and 280 o C for ramp 2 with a holding time of 5 and 9 min respectively using electrospray and m/z positive mode.
Data Analysis
The data obtained were presented as mean ±SEM 
Results
The Effect of Crude Extract of NLE on FBS Level of Alloxan-Induced Diabetic Rats
The effect of graded-doses of NLE on the FBS of alloxan-induced hyperglycaemic rats after 24 hours is presented in Table 
Bioassay Guided Fractionation of NLE and Isolation of Active Compound Column and thin-Layer Chromatography
A total of seven hundred and thirty four (734) 10ml aliquots were collected in test tubes after eluting the crude extract of NLE from column. A trial of various solvent systems showed that the combination of Chloroform, Ethylacetate and Methanol in the ratio (3:2:1) gave the best separation and this solvent system (3:2:1) was used to spot all the eluents in each test tube. Based on their colour reactions under U.V (ultraviolet) light and eluting patterns, the various fractions were pulled into ten (10) fractions of NLE (Fraction 1-10 ).
The various properties of the fractions such as R f (resolution front) values and their yields are presented in Table 2 .
Screening of Fractions of NLE for Bioactivity/Selection of Active Fraction
The various Fractions (1-10) of NLE (50 mg/kg each) and glibenclamide (2 mg/kg) were tested in alloxan-induced hyperglycaemic rats as described earlier in experiment 3:2:3:1. The result is presented in Table 3 . Glibenclamide (2 mg/kg) and Fractions 1,5,6,7,8,9 and 10 produced various levels of percentage decreases in the FBS of the alloxan-induced diabetic rats at various times with most of them having their peak activity at the 6th hour except fraction 1 which had its peak activity of 30% reduction at the 24th hour. Meanwhile Fractions 2, 3, 4 and the negative control caused various levels of percentage increase in the FBS of the diabetic rats over the 24 hour period.
Among the Fractions that caused decrease in the FBS were Fractions 7 and 9 which demonstrated consistent and higher level of decrease in the FBS. Fraction 7 caused low but consistent decrease of FBS over the 24 hour period while Fraction 9 caused 34.7, 40.9 and 66.0 % decreases in FBS at 1, 3 and 6th hours but could not sustain the effect up to 24 hours. Glibenclamide the reference drug showed 8.8, 23.8, 51.9 and 16.3% decreases in FBS at 1, 3, 6 and 24th hour. Fraction 9 was selected as the active fraction for further studies. 
Purification of Active Fraction/Isolation of Pure Compound
The selected Fraction (F9) was further purified using preparative TLC. The purification process yielded six (6) compounds (Plate 1). The six compounds were further screened for antihyperglycaemic activity using 5 mg/kg of each of the sub-fractions. The various sub-fractions showed various time dependent reductions of the FBS in alloxan-induced diabetic rats.
Among them, sub-fraction 9 (2) was selected for its higher antihyperglycaemic activity of 61.4%. The result of the sub-fractions is presented in Table 4 and their R f values are also presented in Table 5 . Based on the above results Fraction 9 sub-fraction 2 (F9:2) was selected as a pure compound (Plate 2) with higher antidiabetic activity of 61.4%, a R f value of 0.524 and a yield of 6 mg.
Characterization and Structural Elucidation
Characterization and structural elucidation were carried out using NMR (nuclear magnetic resonance) and GC-MS (gas chromatography-mass spectroscopy). The data is presented in Fig. 1 . The compound was identified as a long chain unsaturated fatty acid. The molecular structure is shown in Fig. 2 . The chemical name is 9-(4-Nonyl-phenyl)-non-8-enoic acid. The molecular formula and the molecular weight is C 24 H 38 O 2 . and 358.56g respectively.
Bioassay-Guided Isolation and Structural Elucidation of Antidiabetic Principle of
Discussion
The ability of NLE to reduce the FBS (fasting blood sugar) of rats was tested as a means of evaluating its antidiabetic activity through a single intraperitoneal administration of 150 mg/kg of alloxan monohydrate. FBS (fasting blood sugar) is a test of carbohydrate metabolism which measures blood glucose after a fast, which is usually 12-18 h. During this time, the body stimulates the release of the hormone glucagon which in turn releases glucose in to the blood stream through a catabolic process. Under normal circumstances, the body produces and processes insulin to counteract the rise in glucose levels, but in diabetes mellitus this process is impaired, and tested blood glucose levels remain usually high [22] . This procedure was adapted for the bioassay-guided isolation of the antidiabetic principle of NLE (Newbouldia laevis).
Experimental diabetes is usually induced using alloxan monohydrate or Streptozotocin [17, 23] . Alloxan mediates its cytotoxic activity through ROS (reactive oxygen species) especially hydrogen peroxide with simultaneous massive increase in cytosolic Ca 2+ concentration which cuases rapid destruction of β-cells [17, 23] . In this present study, diabetes was induced chemically in the rats through a single intraperitoneal injection of alloxan monohydrate at a dose of 150 mg/kg body weight as described by other workers [17, 23] . The pancreas is especially susceptible to the action of alloxan induced free radical-damage; subsequently, there is a decrease in endogenous insulin and this affects the utilization of glucose by the body tissues. It also leads to elevated blood glucose level, decreased protein content and increased levels of serum cholesterol, triglycerides and other bad lipids [24, 25] . The rats were considered diabetic whenever their FBS was ≥ 7.0 mMol/l and more [18, 26] . In the present study, methanol leaf extract of NLE at doses of 62.5, 125.0 and 250.0 mg/kg body weight caused significant (p < 0.05-0.01) dose and time-dependent decreases in the FBS levels of the alloxan-induced diabetic rats. The time of maximum effect was at the 24th h which was 27.8, 55.3 and 60.2% respectively for the above doses compared to 51.5 % of the reference drug glibenclamide 2 mg/kg. Other workers [10] [11] [12] [13] have reported the dose dependent reduction in FBS by NLE. Evidence abound to show that antidiabetic drugs bring about their effect on diabetes by lowering the blood glucose level of affected animals through various mechanisms [27] [28] [29] . The anti-hyperglycaemic activities of NLE may be due to its ability to restore the functions of pancreatic tissues thereby bringing about an increase in insulin output or insulin utilization just
Bioassay-Guided Isolation and Structural Elucidation of Antidiabetic Principle of Methanol Leaf Extract of Newbouldia laevis (P.Beauv)
524 like many other antidiabetic plants [12, 28] . The process of bioassay-guided fractionation of the NLE through column choromatography yielded 734 of 10 ml aliquots which were pooled into 10 Fractions (F1-10) based on their R f and colour reactions under UV light (Table 2 ). This process was used because it makes available information that will predict the effect of drugs in clinical situations. It also provides a true and real clinical situation in which the expected drug entity is going to operate, thereby providing a wholistic environment. This is a process whereby an extract is fractionated and re-fractionated through chromatography in addition to biological testing until a pure biologically active compound is finally isolated. In other words, it is a step by step process of separating extracted compounds based on differences in their physicochemical properties as well as assessing their biological activities [30] [31] [32] .
The ten (10) fractions obtained were subjected to in vivo biological testing. Their effects on the FBS of alloxan-induced diabetic rats were assessed. Based on the percentage reduction in FBS, Fraction 9 was selected as the most active fraction out of the 10 fractions causing the highest reduction in FBS of 34.7%, 40.9% and 66.0% at 50 mg/kg orally in the treated rats as compared to 8.8%, 23.8% and 51.9% reduction by glibenclamide (2 mg/kg), all at 1, 3, and 6 th h after treatment respectively (Table 3 ).
The active fraction (F.9) was then subjected to further purification through the preparative TLC (thin layer chromatrography). TLC is a method suitable for separating individual components of mixture/substance by using thin layer of silica gel as a stationary phase and a combination of solvents as the mobile phase [20, 30] . TLC has advantage over other forms of separation because of its selectivity, specificity and rapidity in identifying drug substances over other chemical methods. Other advantages are lack of interference from excipients and can be used semiquantitatively [30, 33] . Further purification of Fraction 9 yielded 6 different compounds (Plate 1).The individual effect of these 6 compounds on alloxan-induced diabetic rats showed sub-fraction 2 at a dose of 5 mg/kg orally reduced the FBS of the diabetic rats by 61.4% at the 24th h (Tables 4 and 5 ). Fraction 9 sub-fraction 2 (F.9.2) was suspected to be a pure compound as it yielded one spot on the TLC plate and its total yield was 6 mg and was sent for characterization (Plate 2, Table 5 ). The process of purification increased the potency of the fraction (F9) by five times and the active compound (F9.2) by fifty times (Tables 3 and 4) . Purification process can increase or decrease the activities of pure compounds because some of the activities arise due to synergy of different compounds in the extract [34] .
The characterization and structural elucidation of the active compound of NLE were carried out using 1 H and 13 C NMR and GC mass spectroscopy nuclear magnetic resonance spectroscopy is a modern tool used in determining the molecular structure, dynamics and characterization of materials at molecular level [35] . The basis for the use of NMR is the distinct difference in resonance frequency of every nuclei in the same magnetic field referred to as chemical shift and the nuclei of neighboring NMR active substances known as spin-spin or J-coupling. J-coupling allows the identification from peak intensities. These information from NMR are used to determine accurately the unique molecular structure of compounds [21] . Gas Chromatography-Mass Spectroscopy was used in combination with the NMR to identify the type of compound and compare its structure with other members of the group. There are other procedures that are also used singly or in combination to identify compounds and their molecular structures. Some of them include IR (infrared) spectroscopy, FAB (fast atom bombardment) spectroscopy etc.
The characterization and structural elucidation of F9:2, showed that the active compound responsible for the antidiabetic activity of Newbouldia Laevis is a long chain unsaturated fatty acid 9-(4-Nonyl-phenyl)-non-8-enoic acid with the 
Conclusion
NLE (Newbouldia laevis leaf extract) has demostrated significant antidiabetic activity which is comparable to glibenclamide a standard sulfanylurea, in this study. This establishes the basis for its pharmacological use as an antidiabetic plant in Nigerian folk medicine.The process of purification increased the potency of the fraction by five times and the active compound by fifty times compared to the crude extraxct. The bioassay-guided isolation procedure led to the identification of a long chain polyunsaturated fatty acid [9-(4-Nonyl-phenyl)-non-8-enoic acid] as the antidiabetic compound. Polyunsaturated compounds are well known for their health benefits in chronic and metabolic diseases.
